1. Home
  2. HRL vs BMRN Comparison

HRL vs BMRN Comparison

Compare HRL & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$25.07

Market Cap

11.8B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$64.12

Market Cap

11.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRL
BMRN
Founded
1891
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
11.4B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
HRL
BMRN
Price
$25.07
$64.12
Analyst Decision
Buy
Buy
Analyst Count
6
18
Target Price
$26.50
$88.22
AVG Volume (30 Days)
2.5M
1.6M
Earning Date
05-28-2026
05-04-2026
Dividend Yield
5.61%
N/A
EPS Growth
N/A
N/A
EPS
0.62
0.77
Revenue
$12,106,160,000.00
$1,313,646,000.00
Revenue This Year
$2.66
$15.02
Revenue Next Year
$1.62
$12.23
P/E Ratio
$40.48
$113.81
Revenue Growth
1.55
17.62
52 Week Low
$19.72
$49.26
52 Week High
$29.35
$66.28

Technical Indicators

Market Signals
Indicator
HRL
BMRN
Relative Strength Index (RSI) 50.58 60.32
Support Level $23.98 $53.23
Resistance Level $25.38 $63.47
Average True Range (ATR) 0.51 1.52
MACD -0.09 -0.04
Stochastic Oscillator 21.99 71.76

Price Performance

Historical Comparison
HRL
BMRN

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: